Denosumab Drug Substance from China
Denosumab is RANKL inhibitor monoclonal antibody for osteoporosis and cancer bone metastases. HTS 3002.13.0090 unmixed immunological product. Bulk biotech supply.
Duty Rate — China → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Bone metabolism marker correlation data
• Refrigerated bill of lading mandatory
• No retail intent declaration